Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly - Global

Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly

The purpose of the protocol is evaluate the safety, the pharmacodynamics and the pharmacokinetic of repeated administration of BIM23B065 in subjects with acromegaly.

Related Clinical Trials